22:54:58 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-10-31 Kvartalsrapport 2024-Q3
2024-08-08 Kvartalsrapport 2024-Q2
2024-04-25 Kvartalsrapport 2024-Q1
2024-04-05 Ordinarie utdelning REG1V 0.38 EUR
2024-04-04 Årsstämma 2024
2024-02-15 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-08-10 Kvartalsrapport 2023-Q2
2023-04-27 Kvartalsrapport 2023-Q1
2023-03-24 Ordinarie utdelning REG1V 0.36 EUR
2023-03-23 Årsstämma 2023
2023-02-09 Bokslutskommuniké 2022
2022-10-27 Kvartalsrapport 2022-Q3
2022-08-04 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-11 Ordinarie utdelning REG1V 0.34 EUR
2022-04-08 Årsstämma 2022
2022-02-10 Bokslutskommuniké 2021
2021-10-21 Kvartalsrapport 2021-Q3
2021-08-05 Kvartalsrapport 2021-Q2
2021-04-23 Kvartalsrapport 2021-Q1
2021-03-18 Ordinarie utdelning REG1V 0.32 EUR
2021-03-17 Årsstämma 2021
2021-02-11 Bokslutskommuniké 2020
2020-10-22 Kvartalsrapport 2020-Q3
2020-08-06 Kvartalsrapport 2020-Q2
2020-06-09 Ordinarie utdelning REG1V 0.30 EUR
2020-06-08 Årsstämma 2020
2020-04-22 Kvartalsrapport 2020-Q1
2020-02-20 Bokslutskommuniké 2019
2019-10-24 Kvartalsrapport 2019-Q3
2019-08-15 Kvartalsrapport 2019-Q2
2019-04-16 Kvartalsrapport 2019-Q1
2019-03-21 Ordinarie utdelning REG1V 0.28 EUR
2019-03-20 Årsstämma 2019
2019-02-14 Bokslutskommuniké 2018
2018-10-25 Kvartalsrapport 2018-Q3
2018-08-06 Kvartalsrapport 2018-Q2
2018-04-20 Kvartalsrapport 2018-Q1
2018-03-21 Ordinarie utdelning REG1V 0.78 EUR
2018-03-20 Årsstämma 2018
2018-02-15 Bokslutskommuniké 2017
2017-10-26 Kvartalsrapport 2017-Q3
2017-08-07 Kvartalsrapport 2017-Q2
2017-05-22 Årsstämma 2017
2017-04-20 Kvartalsrapport 2017-Q1
2017-03-23 Ordinarie utdelning REG1V 0.74 EUR
2017-02-16 Bokslutskommuniké 2016
2016-10-31 Kvartalsrapport 2016-Q3
2016-08-08 Kvartalsrapport 2016-Q2
2016-04-25 Kvartalsrapport 2016-Q1
2016-03-16 Ordinarie utdelning REG1V 0.70 EUR
2016-03-15 Årsstämma 2016
2016-02-15 Bokslutskommuniké 2015
2015-10-27 Kvartalsrapport 2015-Q3
2015-08-10 Kvartalsrapport 2015-Q2
2015-04-24 Kvartalsrapport 2015-Q1
2015-03-20 Ordinarie utdelning REG1V 0.45 EUR
2015-03-19 Årsstämma 2015
2015-02-12 Bokslutskommuniké 2014
2014-10-21 Kvartalsrapport 2014-Q3
2014-08-04 Kvartalsrapport 2014-Q2
2014-04-24 Kvartalsrapport 2014-Q1
2014-03-21 Ordinarie utdelning REG1V 0.30 EUR
2014-03-20 Årsstämma 2014
2014-02-12 Bokslutskommuniké 2013
2013-12-11 Bonusutdelning REG1V 0.3
2013-12-09 Extra Bolagsstämma 2013
2013-10-22 Kvartalsrapport 2013-Q3
2013-08-28 Kapitalmarknadsdag 2013
2013-08-05 Kvartalsrapport 2013-Q2
2013-08-02 Bonusutdelning REG1V 0.12
2013-04-19 Kvartalsrapport 2013-Q1
2013-03-28 Split REG1V 10:1
2013-03-22 Ordinarie utdelning REG1V 0.02 EUR
2013-03-21 Årsstämma 2013
2013-02-08 Bokslutskommuniké 2012
2012-10-19 Kvartalsrapport 2012-Q3
2012-08-06 Kvartalsrapport 2012-Q2
2012-04-19 Kvartalsrapport 2012-Q1
2012-03-29 Ordinarie utdelning REG1V 0.02 EUR
2012-03-28 Årsstämma 2012
2012-02-16 Bokslutskommuniké 2011
2011-10-26 Kvartalsrapport 2011-Q3
2011-08-08 Kvartalsrapport 2011-Q2
2011-04-27 Kvartalsrapport 2011-Q1
2011-04-01 Ordinarie utdelning REG1V 0.02 EUR
2011-03-31 Årsstämma 2011
2011-02-16 Bokslutskommuniké 2010
2010-04-09 Ordinarie utdelning REG1V 0.01 EUR
2009-04-16 Ordinarie utdelning REG1V 0.02 EUR
2008-04-03 Ordinarie utdelning REG1V 0.04 EUR
2007-04-09 Ordinarie utdelning REG1V 0.01 EUR
2006-03-31 Ordinarie utdelning REG1V 0.00 EUR
2005-04-01 Ordinarie utdelning REG1V 0.00 EUR
2004-03-29 Ordinarie utdelning REG1V 0.00 EUR
2003-03-24 Ordinarie utdelning REG1V 0.00 EUR
2002-04-15 Ordinarie utdelning REG1V 0.00 EUR

Beskrivning

LandFinland
ListaLarge Cap Helsinki
SektorHälsovård
IndustriMedicinteknik
Revenio är verksamt inom medicinteknik. Inom koncernen återfinns forskning och utveckling av tryckmätningsteknik som används vid behandling av ett flertal sjukdomar såsom glaukom, osteoporos, hudcancer samt astma. Verksamhet innehas på global nivå och drivs via flertalet dotterbolag med vardera affärsinriktning. Bolagets huvudkontor ligger i Vantaa.
2014-02-27 12:00:00
Revenio Group Corporation Stock Exchange Release February 27, 2014 at 13:00
NOTICE OF THE ANNUAL GENERAL MEETING

Notice  is given to the shareholders of  Revenio Group Corporation of the annual
general meeting to be held on 3/20/2014, at 4 p.m. at Finlandia Hall, Veranda 4
hall,  Mannerheimintie 16 e,  FI-00100 Helsinki, Finland  (entrances M4 and K4).
The   reception  of  persons  who  have  registered  for  the  meeting  and  the
distribution of voting tickets will commence at 2.30 p.m.

Before  the meeting at 3 p.m., Timo Hilden, CEO of Icare Finland Oy, will give a
presentation  on  Icare  Finland  Oy's  products  and business. After the annual
general  meeting is held, the shareholders will have the opportunity to meet the
managing directors of the subsidiaries of Revenio Group at a coffee event.


A. Matters on the agenda of the general meeting

The following matters will be considered at the General Meeting:

 1. Opening of the meeting

 2. Calling the meeting to order

 3. Election of the persons to confirm the minutes and to supervise the counting
    of votes

 4. Recording the legal convening of the meeting and quorum

 5. Recording the attendance at the meeting and adoption of the list of votes

 6. Presentation  of the annual accounts, the  Report of the Board of Directors,
    and the auditor's report for the year 2013

  * Review by the President and CEO.

 7. Adoption of the annual accounts

 8. Resolution  on the  use of  the profit  shown on  the balance  sheet and the
    payment of dividend

The  Board of  Directors proposes  to the  AGM that  a per-share dividend of EUR
0.30 be  paid  for  the  financial  year  2013. The  dividend  is  paid to those
shareholders  who,  on  the  dividend  record  date of 3/25/2014, are entered as
shareholders  on the Company's shareholder register as held by Euroclear Finland
Ltd. The Board proposes that the dividend payment date be 4/3/2014.

 9. Resolution on the discharge of the members of the Board of Directors and the
    President and CEO from liability

 10. Resolution on the remuneration of the members of the Board of Directors and
     on the grounds for compensation of travel expenses

The Board of Directors proposes that the remuneration paid to the members of the
Board  of Directors to be elected at the AGM for the term until the close of the
AGM  in 2015 be as follows:  EUR 36,000 for the Chairman  and EUR 18,000 for the
members  of the  Board of  Directors. The  Board of  Directors proposes that 40
percent  of Board members' emoluments  will be settled in  the form of shares in
the Company, while 60 percent will consist of a monetary payment.

Moreover,  the  Board  of  Directors  proposes  that  the travel expenses of the
regular  members of the Board of Directors be compensated in accordance with the
Finnish Tax Administration's decision regarding tax-exempt allowances for travel
expenses.

 11. Resolution on the number of members of the Board of Directors

The  Board of  Directors proposes  that five  regular members  be elected to the
Board of Directors.

 12. Election of the members of the Board of Directors

Shareholders  accounting for  a total  of 29.6 percent  of all shares and voting
rights  in the Company have informed the  Company that they will propose the re-
election of Pekka Tammela, Rolf Fryckman and Ari Korhonen, and election of Pekka
Rönkä and Kyösti Kakkonen as new members to the Company's Board of Directors.

The  CVs of Pekka Rönkä and Kyösti Kakkonen will be presented on the Company web
page at www.revenio.fi.

 13. Resolution on the remuneration of the auditor

The  Board of Directors proposes that remuneration for the auditor shall be paid
against the auditor's reasonable invoice.

 14. Election of the auditor

The  Board of Directors proposes that  PricewaterhouseCoopers Oy, who have named
Authorized Public Accountant Juha Tuomala as the chief auditor, be re-elected as
the auditor.

 15. Authorizing  the Board of  Directors to decide  to repurchase the Company's
     own shares

The  Board of Directors proposes  that the AGM authorize  the Board to decide to
repurchase  a maximum of 785,047 of  the Company's own shares  in one or several
tranches using the Company's unrestricted equity, in which case any buyback will
reduce the amount of the Company's distributable earnings.

The  company may  buy back  shares in  order to  develop its  capital structure,
finance   and  implement  any  corporate  acquisitions  or  other  transactions,
implement share-based incentive plans, or otherwise transfer or cancel them.

The Company may buy back shares, based on

     a. A  bid submitted  to all  shareholders on  equal terms and conditions in
        proportion  to their current holdings in  Company shares and at the same
        price, decided by the Board of Directors; or
     b. In  public trading on marketplaces whose rules and regulations allow the
        Company  to trade in  its own shares.  In such a  case, the Company buys
        back  shares through a directed purchase, that is, in a proportion other
        than   its   shareholders'   holdings   in   Company  shares,  with  the
        consideration  for  the  shares  based  on  their publicly quoted market
        price.

The  Board  proposes  that  the  authorization  be  valid  until 4/30/2015. This
authorization  shall supersede the  buyback authorization granted  at the AGM of
3/21/2013.

 16. Authorization  to the Board of Directors to  decide on a share issue and on
     the  granting of stock options and  other special rights giving entitlement
     to shares

The  Board of Directors proposes that the AGM authorize the Board to decide on a
share  issue  of  a  maximum  of  3,000,000 shares  or  to  grant special rights
(including  stock options) entitling holders to shares as referred to in Chapter
10 Section 1 of the Companies Act, in one or several tranches.

This  authorization  is  proposed  to  be  used  to  finance  and  implement any
prospective  corporate  acquisitions  or  other  transactions,  to implement the
company's  share-based incentive plans, or for  other purposes determined by the
Board.

The authorization is also proposed to grant the Board the right to decide on all
terms  and conditions  governing said  share issue  and the  granting of special
rights, including the subscribers or the grantees of said special rights and the
payable  consideration.  The  authorization  also  includes  the  right to waive
shareholders' pre-emptive subscription rights and covers the issue of new shares
and the transfer of any shares that may be held by the company.

The  Board  proposes  that  the  authorization  be  valid  until 4/30/2015. This
authorization  shall supersede the authorization to  decide on a share issue and
on  the granting of special  rights giving entitlement to  shares granted in the
AGM of 3/21/2013.

 17. Closing of the meeting


B. Documents of the General Meeting

The  abovementioned proposals for  resolution on the  AGM agenda and this notice
are  available on  the website  of Revenio  Group Corporation at www.revenio.fi.
Revenio  Group Corporation's Annual Report,  including the financial statements,
Report of the Board of Directors, and auditor's report, will be available on the
website no later than 2/27/2014. Proposals for resolution and the abovementioned
documents  will also be available at the AGM, and copies of them as well as this
notice will be sent to shareholders upon request. The Minutes of the AGM will be
available on the abovementioned website from 4/3/2014 onwards.

C. Instructions to meeting participants

1. Shareholders registered in the shareholder register

Shareholders who are registered in the Company's shareholder register maintained
by  Euroclear  Finland  Ltd  on  3/10/2014, have  the  right  to attend the AGM.
Shareholders  whose shares are registered  in their personal book-entry accounts
in Finland are registered in the shareholder register of the Company.

Shareholders  who are registered in the  Company's shareholder register and wish
to participate in the AGM must register for the meeting no later than 3/17/2014
at  4:00 p.m., by  which time  registration notices  need to have been received.
Registration options for the General Meeting are:

a) through the Company's website at www.revenio.fi
b) via e-mail to elina.kari@revenio.fi or
c)  by mail to Revenio Group Corporation, General Meeting, Äyritie 22, FI-01510
Vantaa, Finland.

Upon  registration, shareholders should give their name, personal identity code,
address,  telephone number, name  of assistant or  proxy representative, if any,
and the personal identity code of the proxy representative. Personal information
given  by  shareholders  to  Revenio  Group  Corporation  shall  be used only in
connection  with  the  General  Meeting  and  with  the  processing  of  related
registrations. Shareholders, their representatives or proxy representatives must
be able to prove their identity and/or proxy authorization at the meeting venue.


2. Holders of nominee-registered shares

A holder of nominee-registered shares has the right to participate in the AGM by
virtue of such shares based on which the holder would, on 3/10/2014, be entitled
to  be registered  in the  shareholder register  held by  Euroclear Finland Ltd.
Moreover,  in order  to participate  in the  AGM, holders  of nominee-registered
shares  are required to be temporarily registered,  based on such shares, in the
shareholder  register held by Euroclear Finland Ltd, no later than 3/17/2014, at
10:00 a.m.  For nominee-registered shares, this constitutes due registration for
the General Meeting.

Holders  of nominee-registered shares are advised to request, without delay, all
necessary  instructions pertaining to registration  in the temporary shareholder
register,  the  issuing  of  proxy  documents,  and registration for the General
Meeting  from their  asset managers.  The asset  manager's account operator must
sign  up holders  of nominee-registered  shares who  wish to  participate in the
General Meeting for registration to the Company's temporary shareholder register
no later than on the aforementioned date and time.

3. Proxy representation and powers of attorney

Shareholders may participate in the General Meeting and exercise their rights at
the meeting by way of proxy representation. A shareholder's proxy representative
shall  present a dated power of attorney or shall otherwise in a reliable manner
prove  that he/she is authorized to  represent the shareholder. If a shareholder
participates  in the  General Meeting  by way  of several proxy representatives,
representing  the shareholder with shares  in different securities accounts, the
shares  by which  each proxy  representative represents  the shareholder must be
identified upon registration.

Proxy  documents,  if  any,  should  be  delivered as originals to Revenio Group
Corporation,  General Meeting, Äyritie  22, FI-01510 Vantaa, Finland, before the
last date for registration.

4. Other instructions and information

Pursuant  to Chapter 5, Section 25  of the Finnish  Companies Act, a shareholder
who  is present at the  General Meeting has the  right to request information on
matters on the meeting's agenda.

On  the date of  this notice, 2/27/2014, the  total number of  shares in Revenio
Group Corporation is 7,850,479, representing the same number of votes.


Helsinki, 2/27/2014

REVENIO GROUP CORPORATION
BOARD OF DIRECTORS


For additional information:
President&CEO Olli-Pekka Salovaara,
+358 (0)40 567 5520
olli-pekka.salovaara@revenio.fi
http://www.revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi


The Revenio Group in brief

Revenio  is a Finnish health  tech group whose core  business is tonometers. The
Revenio  Health Tech segment comprises the  business operations of Icare Finland
Oy.  The widely patented Icare product family  is the current cornerstone of the
Group's  success.  Revenio  seeks  vigorous  growth  in  health technology, both
organically  and  through  acquisitions  and  mergers.  The  Revenio  Group also
includes  other business operations, which are  grouped under the Technology and
Services  segment.  This  segment's  operations  have a shared global market and
represent  the  cutting  edge  of  technology  products  and  services  in their
industry.  These  businesses  are  extremely  profitable in their industries and
generate positive cash flow.

In  2013, the  Revenio  Group's  net  sales  totaled  EUR 25.7 million, with its
operating  margin standing at 21.7%. The Revenio  Group Corporation is listed on
NASDAQ OMX Helsinki.